Eli Lilly: Q4 in line with expectations

(CercleFinance.com) - Unveiled before Wall Street opens on Wednesday, Eli Lilly's Q4 results included adjusted EPS of 1.
33 dollar, against a 1.14 dollar a year earlier, representing a 17% increase in this benchmark for US companies.

Analysts were also expecting EPS of 1.33 dollar.

The group's sales grew by 5%, to 6.44 billion dollars, after 6.16 billion dollars in Q4 2017. The group's net income reached 1.1 million dollars, against a loss of 1.6 million dollars in the same period a year ago.

Regarding its outlook for 2019, Eli Lilly expects adjusted EPS of 5.55 dollars to 5.65 dollars, with sales between 25.1 billion dollars to 25.6 billion dollars.



Copyright (c) 2019 CercleFinance.com. All rights reserved.